Although overall CV mortality has declined in recent years, patients with clinically manifest CVD remain at increased risk of recurrent CV events. A group of HCPs at UK primary and secondary care centres have recently developed a consensus statement to improve delivery of secondary prevention in the UK.
In 2017 the University of Sheffield was commissioned by Public Health England (PHE) to develop a new return on investment (ROI) tool for cardiovascular disease (CVD) prevention, to be used by national and local decision-makers. The tool focuses on prevention of CVD in six key high-risk groups, identified through the NHS RightCare pathway as being currently underdiagnosed and insufficiently well managed. This includes patients with hypertension, diabetes (type 1 and type 2), non-diabetic hyperglycaemia, atrial fibrillation, chronic kidney disease and high cholesterol (the latter including patients with a QRISK2 score ≥ 10% or familial hypercholesterolaemia).
Behavioural risk factors such as poor diet, smoking and low physical activity, along with high blood pressure, high body mass index and high cholesterol are the main risk factors for cardiovascular disease (CVD). The Heart Age Test is a digital online tool designed to help make sense of an individual’s risk of CVD, the implications of that risk and the behavioural changes needed to reduce that risk.
Community pharmacists are widely recognised as an under-utilised resource within the NHS, in spite of their skills and experience, and the accessibility of their premises. In recent years, community pharmacists have demonstrated the value of the clinical services they offer, particularly in the prevention of cardiovascular disease (CVD).
This case describes a 56-year old male with a productive cough and worsening breathlessness who presented to a practice nurse. This case study was part of a Health Assessment module at the University of Surrey. The case study was supervised by a GP.
Cardiovascular disease (CVD) is the leading cause of death worldwide. Elevated blood pressure (BP) is the main global risk factor for premature morbidity and mortality, and the prevalence of hypertensive heart disease is not declining over time. Improved control of high BP is, therefore, fundamental to further prevention of CVD, and adoption of treatment guidelines can have a positive impact on BP-related outcomes.
There appears to be an association between migraine and cardiovascular disease and especially ischaemic stroke. How real is the absolute risk, what may be the cause, and what, if anything should we tell our patients?
Given that cardiovascular disease (CVD) is responsible for a quarter of all deaths in the UK and is the largest cause of premature mortality in deprived areas, the NHS Long Term Plan recognises that CVD is the single biggest area where the NHS can save lives over the next 10 years.
In the 70 years since the NHS was founded there have indeed been remarkable successes in reducing mortality from common conditions, an important example being deaths due to heart and circulatory disease. Yet the statistics show that there is more to be done to prevent the toll of premature death and years of disability associated with CVD. For this reason, we welcome the continuing focus on CVD prevention as set out in this publication, produced with the support of PHE and NHS England.
Over the last few decades, there has been a great focus on reducing premature deaths due to cardiovascular disease (CVD). Although this is true, CVD still remains a significant cause of disability and death in the United Kingdom. With nearly 7 million people are living with CVD in England, and a quarter of deaths each […]
This article reviews the important and growing role of the NHS Health Check in tackling some of the challenges in prevention and treatment of CVD and other non-communicable diseases.
This NHS Health Check overview shows the target age groups and risk factors assessed during the process. All these details should be recorded on the primary care record. The overview highlights the risk assessment, lifestyle management, clinical assessment and risk management processes involved in the NHS Health Check.